Merck is a stock I trade on and off. I normally look for events or catalysts with Merck to earn decent returns. Otherwise most of the time the option premiums are not worthwhile in my opinion. Today news of the sale of its consumer-products division for $14.2 billion has the stock down 1.9%. I think it is an overreaction. Merck has a lot of products to draw revenue from and $14.2 billion in cash will assist in future research and development as well as acquisitions. A lot of investors are short-sighted when it comes to Merck’s consumer-products division and what future earnings could be. This has resulted in setting up the stock for a trade which I like at the strike price I picked and for future trading possibilities. It is nice to welcome Merck Stock back into my portfolio.
Merck Stock – Trade Alert and Strategy
This article is a trade alert and strategy discussion of Merck Stock. FullyInformed Members can can access this article directly through this link or Members can sign in to the full members site here. Non-members can join here.
Disclaimer: There are risks involved in all investment strategies and investors can and do lose capital. Trade at your own risk. Stocks, options and investing are risky and can result in considerable losses. None of the strategies, stocks or information discussed and presented are financial or trading advice or recommendations. Everything presented and discussed are the author’s own trade ideas and opinions which the author may or may not enter into. The author assumes no liability for topics, ideas, errors, omissions, content and external links and trades done or not done. The author may or may not enter the trades mentioned. Some positions in mentioned stocks may already be held or are being adjusted.
Review Portfolios:
Review All Portfolios for US Stocks
Review All Portfolios for Canada Stocks
